April 26th, 2007
Dendritic Cell-based Vaccine Stops Progression of Pancreatic Cancer
Researchers at the University of Pittsburgh School of Medicine have developed a dendritic cell-based therapeutic vaccine that can successfully halt the progression of pancreatic cancer in some patients three years after vaccination.
The vaccine is made up of a synthetic version of MUC1 (a tumor-associated protein that is expressed by pancreatic tumor cells) combined with the […]
Recent Comments